0001437749-16-031876.txt : 20160513
0001437749-16-031876.hdr.sgml : 20160513
20160513171706
ACCESSION NUMBER: 0001437749-16-031876
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160509
FILED AS OF DATE: 20160513
DATE AS OF CHANGE: 20160513
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NovaBay Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001389545
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 680454536
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5980 HORTON STREET
STREET 2: SUITE 550
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
BUSINESS PHONE: (510) 899-8800
MAIL ADDRESS:
STREET 1: 5980 HORTON STREET
STREET 2: SUITE 550
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pioneer Pharma (Singapore) Pte. Ltd.
CENTRAL INDEX KEY: 0001558885
STATE OF INCORPORATION: U0
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33678
FILM NUMBER: 161649543
BUSINESS ADDRESS:
STREET 1: 33A CHANDER ROAD
CITY: SINGAPORE
STATE: U0
ZIP: 219539
BUSINESS PHONE: 65-98116356
MAIL ADDRESS:
STREET 1: 33A CHANDER ROAD
CITY: SINGAPORE
STATE: U0
ZIP: 219539
4
1
rdgdoc.xml
PIONEER
X0306
4
2016-05-09
0001389545
NovaBay Pharmaceuticals, Inc.
NBY
0001558885
Pioneer Pharma (Singapore) Pte. Ltd.
33A CHANDER ROAD
SINGAPORE
219539
1
Common Stock
2016-05-09
4
A
0
1308901
1.91
A
2389318
D
Warrant
1.91
2016-05-09
4
A
0
654451
0
A
2016-05-09
2020-05-05
Common Stock
654451
835751
D
Share acquisition pursuant to a securities purchase agreement, which is one of a series of securities purchase agreements that the company entered into for the sale of an aggregate of 4,079,058 shares to nine accredited investors. The company expects to sell another 2,094,241 pursuant to those same agreements on July 31, 2016.
/s/ Justin Hall as attorney in fact for Pioneer Pharma (Singapore) Co Ltd
2016-05-13